Clinical characteristics and patterns of medication use of migraneurs in Latin America from 12 cities in 6 countries

被引:43
作者
Morillo, LE [1 ]
Alarcon, F
Aranaga, N
Aulet, S
Chapman, E
Conterno, L
Estevez, E
Garcia-Pedroza, F
Garrido, J
Macias-Islas, M
Monzillo, P
Nunez, L
Plascencia, N
Rodriguez, C
Takeuchi, Y
机构
[1] Hosp Univ San Ignacio, Dept Neurosci, Neurol Unit, Bogota, Colombia
[2] Hosp Eugenio Espejo, Serv Neurol, Quito, Ecuador
[3] Cent Univ Venezuela, Caracas, Venezuela
[4] Univ Nacl Tucuman, Clin Epidemiol Unit, San Miguel De Tucuman, Argentina
[5] Med Sch Marilia, Marilia, Brazil
[6] Inst Commun Humana, Mexico City, DF, Mexico
[7] CMN Occidente IMSS, Guadalajara, Jalisco, Mexico
[8] Hosp Santa Casa Misericordia Sao Pablo, Headache Ctr, Sao Paulo, Brazil
[9] Serv Neurol Adultos CMN 20 Noviembre, Mexico City, DF, Mexico
[10] Fdn Clin Valle Lili, Cali, Colombia
来源
HEADACHE | 2005年 / 45卷 / 02期
关键词
migraine; cultural; Latin American; treatment; disability;
D O I
10.1111/j.1526-4610.2005.05025.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective.-The objective of this study was to document the clinical characteristics of migraine and patterns of medication use in residents 15 years old in 12 Latin American urban communities. Background.-Few large-scale population studies have established the symptoms and disability associated with migraine with or without aura in Latin American urban communities or the pattern of medication use in these regions. Methods.-In this study, subjects in 12 urban communities, from 6 Latin American countries, were surveyed with a validated face-to-face interview questionnaire based on International Headache Society criteria for migraine. The questionnaire was completed during face-to-face interviews with headache sufferers within selected households and included questions about migraine symptoms, migraine-related disability, and the use of health-care resources and medications to treat migraines. Results.-Of the 8618 people available for screening, 62% suffered from headaches. Of individuals with migraine, 42% reported consulting a health-care professional about their headaches. Of the migraineurs, 94.2% reported moderate to severe pain. Associated symptoms of nausea or vomiting, photophobia, phonophobia, and osmophobia were common during migraine attacks in 30.3, 76.4, 85.1, and 47.7% of subjects, respectively. The majority of subjects suffered between one and eight migraines each month. Although no previous diagnosis of migraine was reported by 65% of headache sufferers, migraineurs lost an average of 8 days in the preceding 3 months in any of the following areas: school, work, household chores, and/or social, family, or leisure activities. The agents used most widely to treat migraine were paracetamol and salicylates, while nonsteroidal anti-inflammatory drugs, dypirone, and ergotamines were also commonly used. Medication use varied widely among countries, but was predominantly nonprescription. Conclusions.-Migraine is a common disorder in Latin American urban communities imposing significant burden on individuals, families, and communities. The magnitude of the impact and the range of activities affected by migraine are similar to those of previous reports in other regions. The preponderance of nonprescription medications and the scarcity of migraine-specific triptans from the study findings are especially striking.
引用
收藏
页码:118 / 126
页数:9
相关论文
共 24 条
[11]   Prevalence and burden of migraine in the United States: Data from the American Migraine Study II [J].
Lipton, RB ;
Stewart, WF ;
Diamond, S ;
Diamond, ML ;
Reed, M .
HEADACHE, 2001, 41 (07) :646-657
[12]   Incremental absenteeism due to headaches in migraine: results from the Mig-Access French national cohort [J].
Michel, P ;
Dartigues, JF ;
Duru, G ;
Moreau, J ;
Salamon, R ;
Henry, P .
CEPHALALGIA, 1999, 19 (05) :503-510
[13]  
MORILLO L, 2003, CLIN EVID, P1441
[14]   Prevalence of migraine in Latin America [J].
Morillo, LE ;
Alarcon, F ;
Aranaga, N ;
Aulet, S ;
Chapman, E ;
Conterno, L ;
Estevez, E ;
Garcia-Pedroza, F ;
Garrido, J ;
Macias-Islas, M ;
Monzillo, P ;
Nunez, L ;
Plascencia, N ;
Rodriguez, C ;
Takeuchi, Y .
HEADACHE, 2005, 45 (02) :106-117
[15]   A headache diagnosis project [J].
Pryse-Phillips, W ;
Aubé, M ;
Gawel, M ;
Nelson, R ;
Purdy, A ;
Wilson, K .
HEADACHE, 2002, 42 (08) :728-737
[16]   EPIDEMIOLOGY OF HEADACHE IN A GENERAL-POPULATION - A PREVALENCE STUDY [J].
RASMUSSEN, BK ;
JENSEN, R ;
SCHROLL, M ;
OLESEN, J .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1991, 44 (11) :1147-1157
[17]   HEADACHE IN THE RURAL VILLAGE OF QUIROGA, ECUADOR [J].
SACHS, H ;
SEVILLA, F ;
BARBERIS, P ;
BOLIS, L ;
SCHOENBERG, B ;
CRUZ, M .
HEADACHE, 1985, 25 (04) :190-193
[18]   Migraine pathophysiology and its clinical implications [J].
Silberstein, SD .
CEPHALALGIA, 2004, 24 :2-7
[19]   The diagnostic value of historical features in primary headache syndromes -: A comprehensive review [J].
Smetana, GW .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (18) :2729-2737
[20]   FLUNARIZINE IN PROPHYLAXIS OF CHILDHOOD MIGRAINE - A DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER STUDY [J].
SORGE, F ;
DESIMONE, R ;
MARANO, E ;
NOLANO, M ;
OREFICE, G ;
CARRIERI, P .
CEPHALALGIA, 1988, 8 (01) :1-6